UGRO Capital Limited

NSEI:UGROCAP Stock Report

Market Cap: ₹22.9b

UGRO Capital Valuation

Is UGROCAP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of UGROCAP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: UGROCAP (₹246.22) is trading above our estimate of fair value (₹58.84)

Significantly Below Fair Value: UGROCAP is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for UGROCAP?

Key metric: As UGROCAP is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for UGROCAP. This is calculated by dividing UGROCAP's market cap by their current earnings.
What is UGROCAP's PE Ratio?
PE Ratio17.5x
Earnings₹1.31b
Market Cap₹22.90b

Price to Earnings Ratio vs Peers

How does UGROCAP's PE Ratio compare to its peers?

The above table shows the PE ratio for UGROCAP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average61.2x
543766 Ashika Credit Capital
69.7xn/a₹18.2b
512020 Saraswati Commercial (India)
13.2xn/a₹22.6b
500306 Jaykay Enterprises
131.9xn/a₹14.1b
WEALTH Wealth First Portfolio Managers
30.2xn/a₹16.0b
UGROCAP UGRO Capital
17.5x39.7%₹22.9b

Price-To-Earnings vs Peers: UGROCAP is good value based on its Price-To-Earnings Ratio (17.5x) compared to the peer average (61.2x).


Price to Earnings Ratio vs Industry

How does UGROCAP's PE Ratio compare vs other companies in the IN Capital Markets Industry?

23 CompaniesPrice / EarningsEstimated GrowthMarket Cap
533095 Bengal & Assam
2.9xn/aUS$1.26b
VLSFINANCE VLS Finance
4.1xn/aUS$150.15m
536773 Jindal Poly Investment and Finance
2.4xn/aUS$112.90m
JINDALPHOT Jindal Photo
2.4xn/aUS$100.43m
UGROCAP 17.5xIndustry Avg. 22.9xNo. of Companies34PE020406080100+
23 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: UGROCAP is good value based on its Price-To-Earnings Ratio (17.5x) compared to the Indian Capital Markets industry average (22.5x).


Price to Earnings Ratio vs Fair Ratio

What is UGROCAP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

UGROCAP PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.5x
Fair PE Ratio22.9x

Price-To-Earnings vs Fair Ratio: UGROCAP is good value based on its Price-To-Earnings Ratio (17.5x) compared to the estimated Fair Price-To-Earnings Ratio (22.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst UGROCAP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹246.22
₹385.00
+56.4%
17.4%₹500.00₹335.00n/a4
Nov ’25₹248.81
₹385.00
+54.7%
17.4%₹500.00₹335.00n/a4
Oct ’25₹254.40
₹375.00
+47.4%
10.1%₹430.00₹335.00n/a4
Sep ’25₹235.35
₹385.00
+63.6%
10.1%₹430.00₹335.00n/a3
Aug ’25₹262.70
₹395.00
+50.4%
11.2%₹440.00₹335.00n/a3
Jul ’25₹281.90
₹395.00
+40.1%
11.2%₹440.00₹335.00n/a3
Jun ’25₹284.00
₹395.00
+39.1%
11.2%₹440.00₹335.00n/a3
May ’25₹264.20
₹385.00
+45.7%
9.7%₹425.00₹335.00n/a3
Apr ’25₹236.85
₹410.00
+73.1%
3.7%₹425.00₹395.00n/a2
Mar ’25₹268.05
₹410.00
+53.0%
3.7%₹425.00₹395.00n/a2
Feb ’25₹275.30
₹410.00
+48.9%
3.7%₹425.00₹395.00n/a2
Jan ’25₹272.60
₹410.00
+50.4%
3.7%₹425.00₹395.00n/a2

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies